RCKT vs. BMRN
RCKT (Rocket Pharmaceuticals, Inc.) and BMRN (BioMarin Pharmaceutical Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, RCKT returned -22.19%/yr vs -4.86%/yr for BMRN. At a 0.39 correlation, their price movements are largely independent.
Performance
RCKT vs. BMRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RCKT achieves a -16.81% return, which is significantly lower than BMRN's -8.03% return. Over the past 10 years, RCKT has underperformed BMRN with an annualized return of -22.19%, while BMRN has yielded a comparatively higher -4.86% annualized return.
RCKT
- 1D
- 1.04%
- 1M
- -19.11%
- YTD
- -16.81%
- 6M
- -12.57%
- 1Y
- -1.35%
- 3Y*
- -48.87%
- 5Y*
- -41.43%
- 10Y*
- -22.19%
BMRN
- 1D
- 2.51%
- 1M
- -1.44%
- YTD
- -8.03%
- 6M
- 0.64%
- 1Y
- -3.75%
- 3Y*
- -16.34%
- 5Y*
- -6.84%
- 10Y*
- -4.86%
RCKT vs. BMRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceuticals, Inc. | -16.81% | -72.08% | -58.06% | 53.14% | -10.35% | -60.19% | 140.95% | 53.58% | 41.95% | -57.21% |
BMRN BioMarin Pharmaceutical Inc. | -8.03% | -9.58% | -31.83% | -6.83% | 17.14% | 0.75% | 3.71% | -0.70% | -4.51% | 7.64% |
Correlation
The correlation between RCKT and BMRN is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.46 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Feb 19, 2015 | 0.39 |
Fundamentals
RCKT:
$327.43M
BMRN:
$10.80B
RCKT:
-$1.88
BMRN:
$1.37
RCKT:
1.38
BMRN:
1.74
RCKT:
$0.00
BMRN:
$3.24B
RCKT:
$0.00
BMRN:
$2.46B
RCKT:
-$198.01M
BMRN:
$439.56M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RCKT vs. BMRN — Risk / Return Rank
RCKT
BMRN
RCKT vs. BMRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rocket Pharmaceuticals, Inc. (RCKT) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RCKT | BMRN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.52 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.01 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | -0.03 | -0.17 | +0.14 |
| Martin ratioReturn relative to average drawdown | -0.07 | -0.35 | +0.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RCKT | BMRN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.02 | -0.11 | +0.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.53 | -0.21 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.26 | -0.14 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.17 | 0.11 | -0.28 |
Drawdowns
RCKT vs. BMRN - Drawdown Comparison
The maximum RCKT drawdown since its inception was -96.70%, which is greater than BMRN's maximum drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for RCKT and BMRN.
Loading charts...
Drawdown Indicators
| RCKT | BMRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.70% | -90.58% | -6.12% |
Max Drawdown (1Y)Largest decline over 1 year | -45.47% | -22.49% | -22.98% |
Max Drawdown (3Y)Largest decline over 3 years | -92.71% | -49.83% | -42.88% |
Max Drawdown (5Y)Largest decline over 5 years | -95.24% | -57.64% | -37.60% |
Max Drawdown (10Y)Largest decline over 10 years | -96.46% | -62.09% | -34.37% |
Current DrawdownCurrent decline from peak | -95.86% | -63.35% | -32.51% |
Average DrawdownAverage peak-to-trough decline | -68.51% | -45.51% | -23.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.74% | 10.84% | +9.90% |
Volatility
RCKT vs. BMRN - Volatility Comparison
Rocket Pharmaceuticals, Inc. (RCKT) has a higher volatility of 17.03% compared to BioMarin Pharmaceutical Inc. (BMRN) at 15.30%. This indicates that RCKT's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RCKT | BMRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.03% | 15.30% | +1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 51.18% | 27.79% | +23.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.57% | 34.57% | +45.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.33% | 32.87% | +45.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.04% | 35.51% | +48.53% |
Dividends
RCKT vs. BMRN - Dividend Comparison
Neither RCKT nor BMRN has paid dividends to shareholders.
Financials
RCKT vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Rocket Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RCKT and BMRN have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RCKT has higher volatility (17.03%) compared to BMRN (15.30%). In terms of maximum drawdown, RCKT dropped -96.70% vs BMRN's -90.58%.
RCKT currently has the higher Sharpe Ratio (-0.02 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RCKT and BMRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer